Published in MD Week, June 30th, 2006
This investigator-initiated study is being conducted by Keizo Sugimachi, MD, president, Kyushu Central Hospital in Fukuoka Japan, using Cytori's regenerative cell processing system.
"We believe adipose stem and regenerative cells can have an important impact on the overall treatment of breast cancer patients," said Sugimachi. "If we can successfully use these cells, which are relatively easy to obtain, in conjunction with the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.